Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Not applicableActive Not RecruitingNCT03309033
What this trial is testing

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Malignant Neoplasm
National Cancer Institute (NCI) 946
Not applicableWithdrawnNCT00501189
What this trial is testing

Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities

Who this might be right for
Papillomavirus Infections
Eisenhower Army Medical Center
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 224
Post-approval studies (Phase 4)Study completedNCT00956553
What this trial is testing

Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls

Who this might be right for
HPV Infections
Public Health England 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303751
What this trial is testing

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Who this might be right for
HPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections
Institut d'Investigació Biomèdica de Bellvitge 80
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339163
What this trial is testing

Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*

Who this might be right for
Recurrent Respiratory Papillomatosis (RRP)
Ohio State University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Testing effectiveness (Phase 2)UnknownNCT02710851
What this trial is testing

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 640
Not applicableStudy completedNCT02897232
What this trial is testing

Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Who this might be right for
Papillomavirus InfectionsHealth BehaviorAttitude of Health Personnel+1 more
Louisiana State University Health Sciences Center Shreveport 386
Not applicableNot Yet RecruitingNCT07632963
What this trial is testing

Addressing HPV Vaccine Hesitancy by Co-Designing a Digital Health Intervention

Who this might be right for
HPVVaccine AcceptanceVaccine Decision Making+1 more
Karolinska Institutet 100
Post-approval studies (Phase 4)Enrolling By InvitationNCT07706673
What this trial is testing

ESCUDDO Long Term Follow Up

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Malignant Neoplasm
National Cancer Institute (NCI) 13,700
Large-scale testing (Phase 3)Study completedNCT00779766
What this trial is testing

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 6,081
Testing effectiveness (Phase 2)Active Not RecruitingNCT03036930
What this trial is testing

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Carcinoma
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT00541970
What this trial is testing

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 961
Testing effectiveness (Phase 2)Study completedNCT00054041
What this trial is testing

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia Grade 3Human Papilloma Virus Infection
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Next Page